Indivior Share Discussion Threads

[casholaa] 13/6/2023 15:06

They know it makes sense, possibly had some fomo too hehehe

[pngasef] 13/6/2023 15:03

Morgan Stanley increased their holding. Interesting.

[steeplejack] 12/6/2023 16:27

Early days.Hopefully the bell ringing on Wednesday will get the ball rolling.Perhaps this will mimic GW Pharmaceuticals that listed on Nasdaq back in 2016.GW was acquired by Jazz Pharmaceuticals in 2021 for a handsome sum of around $7bn.There’s a lot of money washing around the US drug industry.

[74tom] 12/6/2023 15:04

Volume negligible at 14k shares vs 509k in the UK, will take a set of results to get this on the radar IMO.

[youngers] 12/6/2023 13:50

Nice pop on Nasdaq. Good arbitrage opportunity to U.K. already

[waldron] 12/6/2023 11:46

If you wish me to put certain new info in header please ask

[steeplejack] 12/6/2023 11:42

That ticker symbol i posted was wrong,sorry….its the same as London trading on Nasdaq Global Select Market.Charles Schwab have rated Indivior as a D which is underperform.Never fear,Schwabs ratings are very conservative and outside of Apple which is rated A,anything a bit ‘frisky’ is treated with caution.

[gregmorg] 12/6/2023 10:22

Mm, Maybe, but there's a long way to go for the shares to even reach the previous high ( £5 in old format before 5 for one consolidation!)Plus of course, that must be something like five years ago when a pound was worth something more?!!. Still, we shall see. Dreams not built in a day!

[steeplejack] 12/6/2023 07:53

Ding dong!

[gibbs1] 12/6/2023 06:59

12 June 2023

For Immediate Release

Indivior to Commence Trading on Nasdaq

Company to Ring Opening Bell June 14 to Bring Awareness to Addiction Treatment;

Company Will Maintain Premium Listing on London Stock Exchange

Richmond, VA, June 12, 2023 - Indivior PLC (LSE: INDV), a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses, today announces that the U.S. Securities & Exchange Commission (SEC) declared its registration statement on Form 20-F effective on June 9. Trading in Indivior ordinary shares on the Nasdaq Global Select Market will commence at U.S. market open today.

Indivior will retain its premium listing on the London Stock Exchange and inclusion in the FTSE 250 index, and its ordinary shares will trade on both exchanges under the ticker symbol "INDV." The Company also notes that no shares are being offered as part of the additional U.S. listing.

[casholaa] 08/6/2023 14:57

Difficult to say, I think that the nasdaq is the general tech listed companies and the US tech 100 is like ftse 100 for the top 100 tech stocks. I could be erroneous though.

[youngers] 08/6/2023 14:36

Tracker funds own something like 16% of US corporates according to an FT article from last year. Not sure that applies to bottom end of Nasdaq though

[ricky46] 08/6/2023 12:54

It would be good to know how many funds track the Nasdaq index that this is joining next week? They will all be buying into this.

[youngers] 06/6/2023 16:18

Great momentum today with a positive finish. Hopefully this builds through the Nasdaq listing next week

[villarich] 06/6/2023 07:08

Back to £20 we go...

[casholaa] 05/6/2023 13:40

US independence was successful. No taxation without representation!

[steeplejack] 05/6/2023 13:15

The marketmakers will be having extra fun arbitraging with the US quote in due course.Charles Schwab in the US don't charge commission and (of course theres no transaction stamp duty to pay)so you can factor in a price differential between the US and UK quotes of around 0.6% ie about 10p even before the MMs get up to their tricks.I always feel appreciative when i can nip into the US market and pay effectively nothing to deal.The very idea must be deeply shocking to the UK government.

[gregmorg] 05/6/2023 09:30

Well, Steeplejack, that could be a really nice start!! Certainly we hope for big gains after this roller coaster of a ride, and all this time, BUT seeing is the real test as we all know!

[steeplejack] 05/6/2023 08:56

ShearClass over on LSE has posted an interesting analysis.Alkermes (ALKS) is a NASDAQ listed pharma that market another opoid dependence drug (vivitrol). Their Q1 revenues were $287m with $96.7m of this coming from vivitrol, up from $84.7m in the prior year. They're trading at an enterprise value of $4.5b, so EV/Sales ratio is ~3.9. INDV is forecasting 2023 sales of $1.01b and has a current EV of ~$2.4b, so is on an EV/Sales of just 2.3x Gives INDV has significantly faster sales growth, higher gross margins & has now removed the legal overhang I think there is significant upside potential over the coming weeks post next Monday's NASDAQ listing. Aligning with the Alkermes EV/s would put the share price at around £26...

[youngers] 05/6/2023 08:41

Thanks 74tom. Great summary and completely agree with your thinking